These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20196918)

  • 1. Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes.
    Souza RP; de Luca V; Meltzer HY; Lieberman JA; Kennedy JL
    Int J Neuropsychopharmacol; 2010 Jul; 13(6):793-8. PubMed ID: 20196918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxytocin and oxytocin receptor gene polymorphisms and risk for schizophrenia: a case-control study.
    Montag C; Brockmann EM; Bayerl M; Rujescu D; Müller DJ; Gallinat J
    World J Biol Psychiatry; 2013 Sep; 14(7):500-8. PubMed ID: 22651577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of serotonin 3A and 3B receptor genes on clozapine treatment response in schizophrenia.
    Souza RP; de Luca V; Meltzer HY; Lieberman JA; Kennedy JL
    Pharmacogenet Genomics; 2010 Apr; 20(4):274-6. PubMed ID: 20168265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oxytocin and genetic variants on brain and behaviour: Implications for treatment in schizophrenia.
    Bartholomeusz CF; Ganella EP; Labuschagne I; Bousman C; Pantelis C
    Schizophr Res; 2015 Nov; 168(3):614-27. PubMed ID: 26123171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response.
    Huang E; Maciukiewicz M; Zai CC; Tiwari AK; Li J; Potkin SG; Lieberman JA; Meltzer HY; Müller DJ; Kennedy JL
    Pharmacogenomics; 2016; 17(2):103-9. PubMed ID: 26666695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response.
    Souza RP; Romano-Silva MA; Lieberman JA; Meltzer HY; MacNeil LT; Culotti JG; Kennedy JL; Wong AH
    J Psychiatr Res; 2010 Aug; 44(11):700-6. PubMed ID: 20116071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome definitions and clinical predictors influence pharmacogenetic associations between HTR3A gene polymorphisms and response to clozapine in patients with schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Srivastava A; Jacob M; Jacob KS
    Psychopharmacology (Berl); 2012 Dec; 224(3):441-9. PubMed ID: 22700043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of oxytocin receptor single nucleotide sequence variants on contractility of human myometrium: an in vitro functional study.
    Füeg F; Santos S; Haslinger C; Stoiber B; Schäffer L; Grünblatt E; Zimmermann R; Simões-Wüst AP
    BMC Med Genet; 2019 Nov; 20(1):178. PubMed ID: 31718582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
    Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
    J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine.
    Taylor DL; Tiwari AK; Lieberman JA; Potkin SG; Meltzer HY; Knight J; Remington G; Müller DJ; Kennedy JL
    Hum Psychopharmacol; 2016 Mar; 31(2):121-34. PubMed ID: 26876050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response.
    Lett TA; Tiwari AK; Meltzer HY; Lieberman JA; Potkin SG; Voineskos AN; Kennedy JL; Müller DJ
    Schizophr Res; 2011 Nov; 132(2-3):121-4. PubMed ID: 21890328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of dopamine receptor D1 rs4532 polymorphism and susceptibility to antipsychotic treatment response.
    de Matos LP; Santana CV; Souza RP
    Psychiatry Res; 2015 Sep; 229(1-2):586-8. PubMed ID: 26213377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia.
    Woodward ND; Jayathilake K; Meltzer HY
    Schizophr Res; 2007 Feb; 90(1-3):86-96. PubMed ID: 17123785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine.
    Zhao AL; Zhao JP; Zhang YH; Xue ZM; Chen JD; Chen XG
    Int J Neurosci; 2005 Nov; 115(11):1539-47. PubMed ID: 16223700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin system polymorphisms rs237887 and rs2740210 variants increase the risk of depression in pregnant women with early abuse.
    Olazábal DE; Bertoni B; Grandi G; Musetti D; Rey G; Sandberg N; Fernández L; Laporte G; Medici F; Nicolaisen-Sobesky E
    Dev Psychobiol; 2023 Jul; 65(5):e22400. PubMed ID: 37338248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine.
    Masellis M; Basile VS; Ozdemir V; Meltzer HY; Macciardi FM; Kennedy JL
    Biol Psychiatry; 2000 Feb; 47(3):252-66. PubMed ID: 10682223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical response to clozapine treatment of 11 chronic patients in a state psychiatric hospital.
    Herman M
    Aust N Z J Ment Health Nurs; 1997 Sep; 6(3):129-33. PubMed ID: 9384012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in Schizophrenia-Related Genes Are Potential Predictors of Antipsychotic Treatment Resistance and Refractoriness.
    Zazueta A; Castillo T; Cavieres Á; González R; Abarca M; Nieto RR; Deneken J; Araneda C; Moya PR; Bustamante ML
    Int J Neuropsychopharmacol; 2022 Sep; 25(9):701-708. PubMed ID: 35416253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.
    Breier AF; Malhotra AK; Su TP; Pinals DA; Elman I; Adler CM; Lafargue RT; Clifton A; Pickar D
    Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.